Disciplined Growth Investors Inc Novo Nordisk A S Transaction History

Disciplined Growth Investors Inc

  • $4.73 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$103.24 - $121.81 $286,903 - $338,509
-2,779 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$93.1 - $112.54 $51,670 - $62,459
-555 Reduced 16.65%
2,779 $309,000
Q4 2021

Feb 14, 2022
BUY
$95.88 - $117.08 $319,663 - $390,344
3,334 New
3,334 $373,000

Others Institutions Holding NVO

# of Institutions
1,948
Shares Held
320M
Call Options Held
5.22M
Put Options Held
6.6M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $238B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Disciplined Growth Investors Inc Portfolio

Follow Disciplined Growth Investors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Disciplined Growth Investors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Disciplined Growth Investors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email